Resmed (RMD) Capital Expenditures (2009 - 2026)
Resmed's (RMD) quarterly Capital Expenditures came in at $33.7 million in Q1 2026, up 61.83% YoY from $20.8 million in Q1 2025, and up 17.92% on a QoQ basis from $28.5 million in Q4 2025.
Resmed (RMD) Capital Expenditures (2009 - 2026) Analysis & Trends
Resmed (RMD) has 18 years of Capital Expenditures data on file, last reported at $33.7 million in Q1 2026.
- Quarterly Capital Expenditures rose 61.83% year-over-year to $33.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $135.7 million (up 61.29% YoY) and the FY2025 annual result came in at $89.9 million, down 9.65% from the prior year.
- Capital Expenditures improved to $33.7 million in Q1 2026, from $28.5 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $48.4 million in Q1 2022 to a low of $17.8 million in Q3 2024.
- A 5-year average of $28.9 million and a median of $28.6 million in 2022 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2024 — Capital Expenditures sank 40.6% — and 2025, when it jumped 140.84%.
- Tracing RMD's Capital Expenditures over 5 years: stood at $27.4 million in 2022, then dropped by 14.61% to $23.4 million in 2023, then dropped by 11.6% to $20.6 million in 2024, then surged by 38.24% to $28.5 million in 2025, then rose by 17.92% to $33.7 million in 2026.
- The last three Capital Expenditures figures came in at $33.7 million (Q1 2026), $28.5 million (Q4 2025), and $43.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 112.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 143.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 374.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 51.13 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 111.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 83.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 86.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 116.00 Mn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | 35.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 51.13 Mn |
| Jun 30, 2026 | 51.13 Mn |
| Mar 31, 2026 | 33.65 Mn |
| Mar 31, 2026 | 33.65 Mn |
| Dec 31, 2025 | 28.54 Mn |
| Dec 31, 2025 | 28.54 Mn |
| Sep 30, 2025 | 42.97 Mn |
| Sep 30, 2025 | 42.97 Mn |
| Jun 30, 2025 | 30.59 Mn |
| Jun 30, 2025 | 30.59 Mn |
| Mar 31, 2025 | 20.80 Mn |
| Mar 31, 2025 | 20.80 Mn |
| Dec 31, 2024 | 20.64 Mn |
| Dec 31, 2024 | 20.64 Mn |
| Sep 30, 2024 | 17.84 Mn |
| Sep 30, 2024 | 17.84 Mn |
| Jun 30, 2024 | 24.88 Mn |
| Jun 30, 2024 | 24.88 Mn |
| Mar 31, 2024 | 21.19 Mn |
| Mar 31, 2024 | 21.19 Mn |